NANOMICRO(SH:688690)2024-11-13 07:34Group 1: Investor Relations Activities - The investor relations activities included specific object research, online meetings, and discussions on Q3 performance [1] - Participants included representatives from Dongwu Securities, Huashang Fund, CITIC Securities, and others [1] - The meetings took place from November 11 to November 12, 2024, in the company conference room [1] Group 2: Company Performance Insights - The demand for GLP-1 has increased significantly, providing more opportunities for domestic filler suppliers [1] - The company has a competitive product line in the GLP-1 drug development sector, contributing to the growth of small molecule business in Q3 [1] - Challenges in the spectrometer business include reduced demand for instrument purchases and declining sales prices due to industry competition [1] Group 3: Strategic Responses - The company has integrated the "filler + consumables" marketing team since Q4 last year, showing positive results in instrument sales [1] - Future strategies include optimizing R&D resources to focus on key product upgrades and controlling long-term project investments [1] - The goal is to achieve profitability in the upcoming year [1]